No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Camber Spine to Roll Out Education Initiatives and Expand Product Portfolio in 2022

Editor: What To Know

  • Camber Spine will be exhibiting and presenting its products (including SPIRA-T, SPIRA-P and ORTHROS) at a number of clinical conferences throughout the year, including AANS/CNS in February, AAOS in March, IMAST and AANS in April, ISASS in June, and other events, including NASS in October, where Camber will be hosting multiple clinical presentations.
  • In addition, Camber's product pipeline is scheduled to produce a number of key product launches throughout 2022, starting with innovative navigation and MIS instruments to be announced later in Q1 and products to compliment a complete posterior approach, also in Q1.
  • Camber will also continue to expand its award-winning Spira and Enza technology platforms in the first three quarters of this year, with a series of product launches, including a full compliment of biologic options.

Camber Spine, a leading innovator in spine and medical technologies has announced a robust calendar of clinical education and product portfolio expansions in 2022.

Camber Spine notes plans for the year include four spine surgical training labs focused on the Oblique Lateral Interbody Fusion Surgery (OLIF) technique. The labs, part of the Camber Education Program, are designed to give surgeons an opportunity to further their experience accessing the anterior spine (L2-S1) through an oblique approach. The program faculty will use didactic sessions, hands-on cadaveric training and case review to provide a full-day session to benefit surgeon attendees. Additional training labs on will be offered throughout the year on ALIF, LLIF, PLIF and TLIF techniques.

Camber Spine will also be offering unique OLIF training opportunities via its one-on-one Clinical Preceptor Training program with Dr. John I. Williams, Spine Surgeon, ORTHO Northeast, Fort Wayne, IN.

In addition, Camber’s product pipeline is scheduled to produce a number of key product launches throughout 2022, starting with innovative navigation and MIS instruments to be announced later in Q1 and products to compliment a complete posterior approach, also in Q1. Camber will also continue to expand its award-winning Spira and Enza technology platforms in the first three quarters of this year, with a series of product launches, including a full compliment of biologic options.

Camber Spine will be exhibiting and presenting its products (including SPIRA-T, SPIRA-P and ORTHROS) at a number of clinical conferences throughout the year, including AANS/CNS in February, AAOS in March, IMAST and AANS in April, ISASS in June, and other events, including NASS in October, where Camber will be hosting multiple clinical presentations.

“We now offer interbody options for anterior column reconstruction from every possible angle,” said Seth Anderson, Camber’s Chief Innovation Officer. “To support this, education and innovation continue to be our top priorities. Our patented and award-winning technology platforms will be expanding significantly this year, so hosting a broad selection of presentation and training opportunities with thought leaders is timely. This is likely to be our most productive year to date in terms of product launches and hands-on training.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy